美国毒药中心报告的吸入剂滥用,2001-2021年
Raymond L Hogge1,2, Henry A Spiller3,4, Sandhya Kistamgari1
1Center for Injury Research and Policy, The Abigail Wexner Research Institute of Nationwide Children's Hospital, Columbus, OH, USA.
Clinical toxicology (Philadelphia, Pa.)
|June 26, 2023
概括
报告给美国中毒中心的吸入剂滥用病例在2010年后显著下降,特别是在青少年中,由于法规限制了. 这凸显了监管行动对公共卫生趋势的影响.
科学领域:
- 公共卫生监督 公共卫生监督
- 毒理学 毒理学 毒理学
- 环境健康政策 环境健康政策
背景情况:
- 吸入剂的滥用构成了重大的公共卫生挑战.
- 了解吸入剂滥用的趋势和特征对于有针对性的干预至关重要.
- 以前的研究还没有完全阐明监管变化对吸入剂滥用模式的影响.
研究的目的:
- 调查2001年至2021年期间向美国中毒中心报告的吸入剂滥用的特征和时间趋势.
- 评估监管行动与吸入剂滥用率的变化之间的关联,特别是在青少年中.
主要方法:
- 利用国家毒物数据系统和美国人口普查局的数据进行分析.
- 检查了人口统计特征,吸入剂类别,医疗保健利用率和医疗结果.
- 在研究期间评估了吸入剂滥用率的基于人口的趋势.
主要成果:
- 报告共有26,446起吸入药物滥用案例,其中男性和单一物质滥用占主导地位.
- 吸入剂滥用的总体率从2001年到2010年增加,然后到2021年急剧下降.
- 2010年观察到"自由和其他推进剂"滥用的显著趋势逆转,与EPA法规相吻合,影响了13-19岁的年龄组.
结论:
- 尽管2010年后出现了下降,但吸入剂的滥用仍然是一个公共卫生问题.
- 环境保护局2010年对的监管可能导致了吸入剂滥用率的下降.
- 这项研究说明了监管政策对公共卫生结果的重大影响.
相关概念视频
01:20Inhalational Anesthetics: Overview
357
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
357
01:23Inhaled Medications
321
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
321
01:36Types of Toxins
1.8K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.8K
01:16Drugs Used in Upper Respiratory Disorders: Overview
297
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
297
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:17Drugs Used in Lower Respiratory Disorders: Overview
504
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
504